Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact

Panel Urges FDA to Protect Patients

by Brayton Purcell LLP | May 26, 2015 | Defective Medical Devices

Last week, a federal panel made up of doctors, health experts, and consumer representatives concluded that the medical duodenoscopes associated with the superbug outbreak at UCLA Medical Center are unsafe as currently designed. They urged the United States Food and Drug Administration (FDA) to do more to protect patients.

exam room in a hospital

The medical devices, which have been associated with the carbapenem-resistant Enterobacteriaceae (CRE) outbreak in several patients, are currently made by three manufacturers. Of the makers, Olympus is the most dominant, with its TJF-Q160V model under scrutiny. Bacteria can become caught in an area of the device that is not accessible during cleaning and disinfection before it is used on another patient. The duodenoscopes were used in about 670,000 endoscopic retrograde cholangiopancreatography (ERCP) procedures in 2014 alone.

Olympus and the other manufacturers were not present at last week’s panel. The panel stressed that between 10% and 30% of the scopes used in hospitals are contaminated.

Even more shocking for consumers is finding out that Olympus began selling their medical device in 2010 without seeking FDA approval. They had warned European safety regulators of the contamination problems since 2012, but did not seek U.S. FDA clearance until late 2013/early 2014.

If you or someone you know has been affected by a duodenoscope manufactured by Olympus or another manufacturer, you might be entitled to compensation. Don’t hesitate to contact an attorney to discuss your legal options today.

Recent Posts

  • Who is Most at Risk of Mesothelioma?
  • Boiler Room Workers and Asbestos Exposure
  • Mitigating the financial impact of mesothelioma treatments
  • The EPA’s difficulty with data disclosure
  • Judge orders EPA to close loopholes on asbestos-related reporting

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us